{"id":105056,"date":"2026-06-29T21:49:56","date_gmt":"2026-06-29T16:19:56","guid":{"rendered":"https:\/\/seminarsonly.com\/news\/?p=105056"},"modified":"2026-06-29T22:30:37","modified_gmt":"2026-06-29T17:00:37","slug":"glp-1-medicare-pilot-program","status":"publish","type":"post","link":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/","title":{"rendered":"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026"},"content":{"rendered":"<p><!-- QUICK ANSWER BOX --><\/p>\n<div style=\"background: linear-gradient(135deg, #e8f5e9 0%, #c8e6c9 100%); border-left: 5px solid #2e7d32; border-radius: 8px; padding: 24px; margin: 24px 0; box-shadow: 0 2px 8px rgba(0,0,0,0.08);\">\n<h2 style=\"color: #1b5e20; margin-top: 0; font-size: 22px; font-family: Georgia, serif;\">Quick Answer<\/h2>\n<p style=\"color: #2e4a2e; font-size: 16px; line-height: 1.7; margin-bottom: 0;\">Starting <strong>July 1, 2026<\/strong>, Medicare&#8217;s GLP-1 Bridge pilot program gives eligible Part D beneficiaries access to <strong>Wegovy, Zepbound, and Foundayo<\/strong> for a flat <strong>$50 per month<\/strong>. The program runs through December 31, 2027. To qualify, you need a BMI of 27+ plus a related health condition, or a BMI of 35+ with no other conditions required. Your doctor must submit a prior authorization request.<\/p>\n<\/div>\n<p><!-- FEATURED IMAGE --><br \/>\n<img decoding=\"async\" style=\"border-radius: 8px; margin: 20px 0; box-shadow: 0 4px 12px rgba(0,0,0,0.1);\" src=\"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg\" alt=\"Medicare card with GLP-1 medication pen injectors on blue healthcare background\" width=\"1200\" height=\"675\" \/><\/p>\n<p><!-- INTRODUCTION --><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; color: #333;\">For years, Medicare beneficiaries watched from the sidelines as GLP-1 medications like Wegovy and Zepbound transformed weight management for millions of Americans. The catch? Medicare couldn&#8217;t cover these drugs when prescribed for obesity. That changes on July 1, 2026.<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">The Centers for Medicare and Medicaid Services (CMS) is launching the Medicare GLP-1 Bridge, a pilot program that marks the first time Medicare will directly cover weight-loss medications. I&#8217;ve spent time digging through CMS announcements, manufacturer agreements, and eligibility documents to put together everything you need to know. No fluff, just the facts that matter.<\/p>\n<p><!-- TABLE OF CONTENTS --><\/p>\n<div style=\"background-color: #f3f6f9; border: 1px solid #d0d9e6; border-radius: 8px; padding: 24px; margin: 28px 0;\">\n<h3 style=\"color: #1a365d; margin-top: 0; font-size: 20px; font-family: Georgia, serif;\">What You&#8217;ll Learn in This Guide<\/h3>\n<ul style=\"margin-bottom: 0; padding-left: 20px;\">\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#what-is\">What the GLP-1 Medicare pilot program actually covers<\/a><\/li>\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#drugs-covered\">Which medications are included (and which aren&#8217;t)<\/a><\/li>\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#eligibility\">Eligibility requirements and BMI tiers<\/a><\/li>\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#costs\">What you&#8217;ll pay out of pocket<\/a><\/li>\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#enroll\">How to enroll starting July 2026<\/a><\/li>\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#important-catches\">The fine print you need to read<\/a><\/li>\n<li><a style=\"color: #2563eb; text-decoration: none;\" href=\"#tldr\">TLDR: The bottom line<\/a><\/li>\n<\/ul>\n<\/div>\n<p><!-- H2 SECTION --><\/p>\n<h2 id=\"what-is\" style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">What Is the Medicare GLP-1 Bridge Program?<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">The Medicare GLP-1 Bridge is a time-limited demonstration program created by CMS under Section 402 authority. It&#8217;s designed to test whether providing Medicare beneficiaries access to GLP-1 weight-loss medications at a reduced cost improves health outcomes while keeping spending manageable.<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Here&#8217;s the backstory. Medicare has been prohibited from covering weight-loss medications since the Part D program was created in 2003. That prohibition stayed in place even as the science around obesity changed dramatically. When GLP-1 drugs showed they could do more than help people shed pounds (reducing heart attacks, improving kidney function, lowering stroke risk), pressure mounted to rethink the policy.<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"nd9nGMWlzx\"><p><a href=\"https:\/\/seminarsonly.com\/news\/api-400-this-organization-has-been-disabled\/\">API 400 &#8220;This Organization Has Been Disabled&#8221;: Fix It in 5 Minutes<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cAPI 400 \u201cThis Organization Has Been Disabled\u201d: Fix It in 5 Minutes\u201d \u2014 Seminarsonly.com\" src=\"https:\/\/seminarsonly.com\/news\/api-400-this-organization-has-been-disabled\/embed\/#?secret=pLf8N1Jcob#?secret=nd9nGMWlzx\" data-secret=\"nd9nGMWlzx\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">The Trump administration struck what it called a &#8220;most-favored-nation&#8221; deal with Novo Nordisk and Eli Lilly, the two largest GLP-1 manufacturers. The result: the Bridge program, which sidesteps the statutory ban by operating <em>outside<\/em> the standard Part D system. CMS Administrator Dr. Mehmet Oz put it plainly: &#8220;These treatments are a major medical advancement, but too many seniors are currently unable to access them due to high cost. The Medicare GLP-1 Bridge changes that.&#8221;<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Originally, the Bridge was set to run just six months (July through December 2026). But in April 2026, CMS announced it would <strong>extend the program through December 31, 2027<\/strong>, giving beneficiaries a full 18 months of access. The longer timeline also gives CMS more data to work with as it evaluates a permanent solution.<\/p>\n<p><!-- H2 SECTION --><\/p>\n<h2 id=\"drugs-covered\" style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">Which GLP-1 Drugs Are Covered (and Which Aren&#8217;t)?<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Not every GLP-1 medication made the list. The Bridge program specifically targets drugs FDA-approved for weight reduction, while leaving diabetes medications under regular Part D rules. Here&#8217;s the breakdown:<\/p>\n<p><!-- COLORED TABLE --><\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; font-size: 16px; box-shadow: 0 2px 8px rgba(0,0,0,0.08); border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: linear-gradient(135deg, #1565c0 0%, #0d47a1 100%);\">\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2);\">Medication<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2);\">FDA Approval<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2);\">Covered Under Regular Part D?<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600;\">Covered Under GLP-1 Bridge?<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background-color: #e3f2fd;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; font-weight: 600; color: #0d47a1;\">Wegovy (semaglutide)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; color: #333;\">Weight Loss \/ Cardiovascular Risk<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; color: #333;\">Only for reducing severe cardiovascular risk<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; color: #2e7d32; font-weight: 600;\">Yes &#8211; All formulations<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: 600; color: #0d47a1;\">Zepbound (tirzepatide)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #333;\">Weight Loss<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #c62828; font-weight: 500;\">No<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #2e7d32; font-weight: 600;\">Yes &#8211; KwikPen only<\/td>\n<\/tr>\n<tr style=\"background-color: #e3f2fd;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; font-weight: 600; color: #0d47a1;\">Foundayo (oral semaglutide)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; color: #333;\">Weight Loss<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; color: #c62828; font-weight: 500;\">No<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #bbdefb; color: #2e7d32; font-weight: 600;\">Yes &#8211; All formulations<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; font-weight: 600; color: #0d47a1;\">Ozempic \/ Mounjaro<\/td>\n<td style=\"padding: 12px 18px; color: #333;\">Type 2 Diabetes<\/td>\n<td style=\"padding: 12px 18px; color: #2e7d32; font-weight: 500;\">Yes (strictly for Type 2 Diabetes)<\/td>\n<td style=\"padding: 12px 18px; color: #757575; font-weight: 500;\">No &#8211; Use regular Part D<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">A couple of things stand out here. First, Ozempic isn&#8217;t part of the Bridge at all because it remains covered under standard Part D rules for diabetes. If you&#8217;re already getting Ozempic covered for type 2 diabetes, nothing changes for you. Second, the manufacturers have hinted that <strong>new GLP-1 oral pills<\/strong> could be added mid-2026 if the FDA approves them in time.<\/p>\n<p><!-- H2 SECTION --><\/p>\n<h2 id=\"eligibility\" style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">Who Qualifies? The Three BMI Tiers Explained<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Eligibility for the Bridge program isn&#8217;t automatic. Your doctor needs to submit a prior authorization request confirming that you meet one of three clinical tiers. CMS designed this tiered system to prioritize patients with the highest health risks.<\/p>\n<p><!-- ELIGIBILITY TABLE --><\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; font-size: 16px; box-shadow: 0 2px 8px rgba(0,0,0,0.08); border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: linear-gradient(135deg, #6a1b9a 0%, #4a148c 100%);\">\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2); width: 15%;\">Tier<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2); width: 20%;\">BMI Requirement<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2); width: 35%;\">Required Health Conditions<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; width: 30%;\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background-color: #f3e5f5;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #ce93d8; font-weight: bold; color: #4a148c;\">Tier 1<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #ce93d8; color: #333; font-weight: 600;\">35 or higher<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #ce93d8; color: #333;\">None required<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #ce93d8; color: #555;\">Highest priority. No additional conditions needed.<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: bold; color: #4a148c;\">Tier 2<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #333; font-weight: 600;\">30 or higher<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #333;\">Heart failure, uncontrolled hypertension, or chronic kidney disease<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #555;\">Must have at least one comorbid condition.<\/td>\n<\/tr>\n<tr style=\"background-color: #f3e5f5;\">\n<td style=\"padding: 12px 18px; font-weight: bold; color: #4a148c;\">Tier 3<\/td>\n<td style=\"padding: 12px 18px; color: #333; font-weight: 600;\">27 or higher<\/td>\n<td style=\"padding: 12px 18px; color: #333;\">Prediabetes, history of heart attack or stroke, or peripheral artery disease<\/td>\n<td style=\"padding: 12px 18px; color: #555;\">Lowest BMI threshold but requires diagnosed condition.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Your prescriber needs to document that the medication is being prescribed for weight reduction and maintenance, not just general wellness. CMS will review each prior authorization request through a centralized processor (currently set to be Humana).<\/p>\n<p><!-- INTERNAL LINK 1 --><\/p>\n<div style=\"background-color: #fff8e1; border-left: 4px solid #ff8f00; border-radius: 6px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"margin: 0; font-size: 16px; color: #5d4037;\"><strong>Related:<\/strong> Learn more about <a style=\"color: #e65100; text-decoration: underline; font-weight: 600;\" href=\"https:\/\/seminarsonly.com\/news\/medicare-gov-plan-compare-2026-getting-started\/\">how Medicare Part D prescription coverage works<\/a> and what costs to expect beyond the GLP-1 Bridge program.<\/p>\n<\/div>\n<p><!-- H2 SECTION --><\/p>\n<h2 id=\"costs\" style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">What You&#8217;ll Actually Pay: Cost Breakdown<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">The headline number is straightforward: <strong>$50 per month<\/strong> for a 30-day supply. But the full financial picture has a few more layers worth understanding.<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Manufacturers have agreed to a net price of $245 per monthly supply. You pay $50. CMS handles the rest through the demonstration program&#8217;s separate funding structure. Chris Klomp, Director of Medicare at HHS, noted that this approach was designed to make costs &#8220;simpler, more predictable, and more consistent.&#8221;<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">But here&#8217;s something you should know: that $50 monthly copay <strong>does not count<\/strong> toward your regular Part D out-of-pocket maximum. The Bridge operates entirely outside the Part D system, which means those payments don&#8217;t get applied to the $2,100 annual cap that took effect in 2025.<\/p>\n<p><!-- COST COMPARISON TABLE --><\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; font-size: 16px; box-shadow: 0 2px 8px rgba(0,0,0,0.08); border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: linear-gradient(135deg, #2e7d32 0%, #1b5e20 100%);\">\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2);\">Cost Factor<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2);\">Under GLP-1 Bridge<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600;\">Under Standard Part D<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background-color: #e8f5e9;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #a5d6a7; font-weight: 600; color: #1b5e20;\">Monthly medication cost<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #a5d6a7; color: #2e7d32; font-weight: bold;\">$50 flat copay<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #a5d6a7; color: #c62828; font-weight: 600;\">$325-$430 (25-33% coinsurance)<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: 600; color: #1b5e20;\">Annual out-of-pocket max<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #555;\">Does not apply<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #333;\">$2,100 cap<\/td>\n<\/tr>\n<tr style=\"background-color: #e8f5e9;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #a5d6a7; font-weight: 600; color: #1b5e20;\">Counts toward deductible<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #a5d6a7; color: #c62828; font-weight: 600;\">No<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #a5d6a7; color: #2e7d32; font-weight: 600;\">Yes<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: 600; color: #1b5e20;\">Extra Help \/ LIS subsidies<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #c62828; font-weight: 600;\">Not available<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #2e7d32; font-weight: 600;\">Available if you qualify<\/td>\n<\/tr>\n<tr style=\"background-color: #e8f5e9;\">\n<td style=\"padding: 12px 18px; font-weight: 600; color: #1b5e20;\">Manufacturer net price<\/td>\n<td style=\"padding: 12px 18px; color: #333;\">$245\/month (negotiated)<\/td>\n<td style=\"padding: 12px 18px; color: #333;\">$700-$800\/month (typical net)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">If you currently receive Extra Help or Low-Income Subsidies (LIS), those protections don&#8217;t apply to the Bridge program. Your copay stays at $50 regardless of income level. For some beneficiaries who receive full LIS under Part D, this could actually mean paying more than you would under the standard benefit. It&#8217;s worth running the numbers with your plan or a <a style=\"color: #1565c0; text-decoration: underline;\" href=\"https:\/\/www.shiptacenter.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">State Health Insurance Assistance Program (SHIP) counselor<\/a>.<\/p>\n<p><!-- H2 SECTION --><\/p>\n<h2 id=\"enroll\" style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">How to Enroll: Step-by-Step<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Enrollment doesn&#8217;t work like typical Part D sign-up. Since the Bridge is a demonstration program operating outside normal Part D channels, the process has its own workflow. Here&#8217;s what you need to do:<\/p>\n<p><!-- STEP BY STEP TABLE --><\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; font-size: 16px; box-shadow: 0 2px 8px rgba(0,0,0,0.08); border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: linear-gradient(135deg, #00695c 0%, #004d40 100%);\">\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2); width: 8%;\">Step<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600; border-right: 1px solid rgba(255,255,255,0.2); width: 25%;\">Action<\/th>\n<th style=\"color: #fff; padding: 14px 18px; text-align: left; font-weight: 600;\">What You Need to Know<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background-color: #e0f2f1;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #80cbc4; font-weight: bold; color: #00695c; font-size: 18px;\">1<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #80cbc4; font-weight: 600; color: #004d40;\">Confirm Part D enrollment<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #80cbc4; color: #333;\">You must be enrolled in a Medicare Part D plan or a Medicare Advantage plan with drug coverage. The Bridge doesn&#8217;t replace your plan; it runs alongside it.<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: bold; color: #00695c; font-size: 18px;\">2<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: 600; color: #004d40;\">Schedule a doctor visit<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #333;\">Talk to your primary care physician or endocrinologist. They&#8217;ll need to verify your BMI and any qualifying health conditions.<\/td>\n<\/tr>\n<tr style=\"background-color: #e0f2f1;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #80cbc4; font-weight: bold; color: #00695c; font-size: 18px;\">3<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #80cbc4; font-weight: 600; color: #004d40;\">Get prior authorization<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #80cbc4; color: #333;\">Your doctor submits a PA request to CMS through the central processor, attesting that you meet one of the three BMI tiers and are being prescribed the drug for weight reduction.<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffff;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: bold; color: #00695c; font-size: 18px;\">4<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; font-weight: 600; color: #004d40;\">Wait for approval<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e0e0e0; color: #333;\">CMS or the central processor reviews your case. Response times haven&#8217;t been published yet, but most Part D PA decisions come within 72 hours for urgent requests.<\/td>\n<\/tr>\n<tr style=\"background-color: #e0f2f1;\">\n<td style=\"padding: 12px 18px; font-weight: bold; color: #00695c; font-size: 18px;\">5<\/td>\n<td style=\"padding: 12px 18px; font-weight: 600; color: #004d40;\">Fill your prescription<\/td>\n<td style=\"padding: 12px 18px; color: #333;\">Take your approval to a participating pharmacy. You pay $50 at the counter. The pharmacy submits the claim to the central processor for reimbursement.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">CMS has indicated that beneficiaries don&#8217;t need to &#8220;apply&#8221; to the Bridge program directly. Instead, the process kicks off when your doctor submits the prior authorization request. Once you&#8217;re approved, your $50 copay should work at any participating pharmacy.<\/p>\n<p><!-- H2 SECTION --><\/p>\n<h2 id=\"important-catches\" style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">The Fine Print: 5 Things to Watch Out For<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Pilot programs come with quirks. The Bridge has several features that differ from standard Medicare coverage, and some of them could trip you up if you&#8217;re not prepared.<\/p>\n<ol style=\"font-size: 17px; line-height: 1.9; color: #333; padding-left: 24px;\">\n<li style=\"margin-bottom: 14px;\"><strong style=\"color: #c62828;\">It runs outside Part D.<\/strong> Even though you need Part D to qualify, the Bridge program is managed separately. Humana is serving as the central claims processor, not your regular Part D insurer. This means your usual pharmacy network might not apply.<\/li>\n<li style=\"margin-bottom: 14px;\"><strong style=\"color: #c62828;\">Payments don&#8217;t count toward your out-of-pocket max.<\/strong> The $50 monthly copays won&#8217;t accumulate toward the $2,100 annual Part D spending cap. If you take other expensive medications, this separation matters.<\/li>\n<li style=\"margin-bottom: 14px;\"><strong style=\"color: #c62828;\">No Extra Help or LIS.<\/strong> Low-income subsidies that normally reduce Part D costs don&#8217;t extend to the Bridge. Everyone pays the same $50, which helps higher-income beneficiaries but may not help those who currently get medications nearly free through LIS.<\/li>\n<li style=\"margin-bottom: 14px;\"><strong style=\"color: #c62828;\">Coverage ends December 31, 2027.<\/strong> This is a time-limited demonstration. After that date, you&#8217;ll need Congress to pass permanent legislation (like the Treat and Reduce Obesity Act) or CMS to establish a permanent model to keep coverage going.<\/li>\n<li style=\"margin-bottom: 14px;\"><strong style=\"color: #c62828;\">The BALANCE Model is delayed indefinitely.<\/strong> Originally, the Bridge was supposed to hand off to a permanent BALANCE Model in January 2027. CMS announced in May 2026 that the BALANCE Model for Part D has been delayed with no new start date. The Bridge extension through 2027 fills that gap, but long-term coverage remains uncertain.<\/li>\n<\/ol>\n<p><!-- EXTERNAL LINK 1 --><\/p>\n<div style=\"background-color: #fce4ec; border-left: 4px solid #c62828; border-radius: 6px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"margin: 0; font-size: 16px; color: #4a0000;\"><strong>Source:<\/strong> For official program details, visit the <a style=\"color: #c62828; text-decoration: underline; font-weight: 600;\" href=\"https:\/\/www.cms.gov\/newsroom\/press-releases\/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries\" target=\"_blank\" rel=\"noopener noreferrer\">official CMS press release on the GLP-1 Bridge program<\/a>.<\/p>\n<\/div>\n<p><!-- H2 SECTION --><\/p>\n<h2 style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">What About Medicaid Coverage?<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">The picture for Medicaid beneficiaries is different and more complicated. Under the GENEROUS model announced in late 2025, state Medicaid programs can opt in to provide lower-priced GLP-1 medications to enrollees. But participation isn&#8217;t mandatory. Each state must submit a letter of intent and negotiate its own agreement.<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">This means coverage will vary significantly depending on where you live. Some states may move quickly to add GLP-1 coverage; others may not participate at all. The net prices for Medicaid programs are confidential, so we don&#8217;t yet know what copays state enrollees will face. If you&#8217;re dual-eligible (enrolled in both Medicare and Medicaid), your Medicare Bridge eligibility takes precedence for the medications covered under that program.<\/p>\n<p><!-- H2 SECTION --><\/p>\n<h2 style=\"color: #1565c0; font-size: 28px; font-family: Georgia, serif; border-bottom: 3px solid #42a5f5; padding-bottom: 10px; margin-top: 36px;\">The Road Ahead: What Happens After 2027?<\/h2>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Long-term coverage hinges on a few moving pieces. The Treat and Reduce Obesity Act (TROA), which has been introduced in multiple sessions of Congress, would permanently remove the statutory ban on weight-loss drug coverage in Medicare. The bill has bipartisan sponsors but hasn&#8217;t reached the floor for a vote yet.<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">Separately, Medicare drug price negotiation under the Inflation Reduction Act has already selected Ozempic and Wegovy for 2027 price setting. CMS must announce the negotiated prices by November 30, 2025, with those prices taking effect January 1, 2027. It&#8217;s not yet clear whether the negotiated prices will align with the $245 net price in the Bridge agreement, but the convergence of these two tracks suggests costs should stay lower than list prices either way.<\/p>\n<p style=\"font-size: 17px; line-height: 1.8; color: #333;\">A 2024 analysis published in JAMA Network Open projected that covering GLP-1s for obesity treatment would reach about 3 million Medicare beneficiaries over 10 years, with total drug costs of roughly $65.9 billion. Health care savings from reduced comorbidities were estimated at $18.2 billion, leaving a net increase in spending of $47.7 billion. Whether Congress views that investment as worthwhile may determine what happens when the Bridge ends.<\/p>\n<p><!-- INTERNAL LINK 2 --><\/p>\n<div style=\"background-color: #fff8e1; border-left: 4px solid #ff8f00; border-radius: 6px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"margin: 0; font-size: 16px; color: #5d4037;\"><strong>Next read:<\/strong> Check out our guide on <a style=\"color: #e65100; text-decoration: underline; font-weight: 600;\" href=\"https:\/\/seminarsonly.com\/news\/medicare-open-enrollment-2026-major-changes-for-2026\/\">how Medicare drug price negotiation works under the Inflation Reduction Act<\/a> and which medications will see negotiated prices in 2027.<\/p>\n<\/div>\n<p><!-- EXTERNAL LINK 2 --><\/p>\n<div style=\"background-color: #fce4ec; border-left: 4px solid #c62828; border-radius: 6px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"margin: 0; font-size: 16px; color: #4a0000;\"><strong>Research:<\/strong> For a deeper dive into the fiscal impact, see the <a style=\"color: #c62828; text-decoration: underline; font-weight: 600;\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12032556\/\" target=\"_blank\" rel=\"noopener noreferrer\">JAMA Network Open study on the 10-year fiscal impact of expanded Medicare GLP-1 coverage<\/a>.<\/p>\n<\/div>\n<p><!-- TLDR BOX --><\/p>\n<div id=\"tldr\" style=\"background: linear-gradient(135deg, #fff3e0 0%, #ffe0b2 100%); border: 2px solid #ef6c00; border-radius: 10px; padding: 28px; margin: 36px 0; box-shadow: 0 4px 16px rgba(239,108,0,0.12);\">\n<h2 style=\"color: #e65100; margin-top: 0; font-size: 24px; font-family: Georgia, serif;\">TLDR: The Bottom Line<\/h2>\n<ul style=\"color: #4e342e; font-size: 16px; line-height: 1.8; margin-bottom: 0; padding-left: 20px;\">\n<li>The <strong>Medicare GLP-1 Bridge<\/strong> launches <strong>July 1, 2026<\/strong> and runs through <strong>December 31, 2027<\/strong><\/li>\n<li>Eligible beneficiaries pay a flat <strong>$50\/month<\/strong> for Wegovy, Zepbound KwikPen, or Foundayo<\/li>\n<li>You need <strong>Medicare Part D<\/strong> and must meet <strong>BMI tier requirements<\/strong> (27+ with conditions, or 35+ without)<\/li>\n<li>Your doctor must submit a <strong>prior authorization request<\/strong> with documented BMI and conditions<\/li>\n<li>The program operates <strong>outside Part D<\/strong> rules, so payments don&#8217;t count toward your annual out-of-pocket max<\/li>\n<li><strong>Extra Help and LIS subsidies don&#8217;t apply<\/strong> to the Bridge program<\/li>\n<li>The BALANCE permanent model has been <strong>delayed indefinitely<\/strong>; the Bridge extension is the only pathway for now<\/li>\n<li>Congressional action (like the <strong>Treat and Reduce Obesity Act<\/strong>) would be needed for permanent coverage beyond 2027<\/li>\n<\/ul>\n<\/div>\n<p><!-- ABOUT \/ E-E-A-T SECTION --><\/p>\n<div style=\"background-color: #f5f5f5; border: 1px solid #e0e0e0; border-radius: 8px; padding: 24px; margin: 32px 0;\">\n<h3 style=\"color: #424242; margin-top: 0; font-size: 20px; font-family: Georgia, serif;\">About This Guide<\/h3>\n<p style=\"color: #616161; font-size: 15px; line-height: 1.7; margin-bottom: 12px;\">This article was compiled from official CMS announcements, manufacturer disclosures, peer-reviewed research from JAMA Network Open, and policy analysis from the Kaiser Family Foundation (KFF) and the STOP Obesity Alliance. Information is current as of June 2026. Program details may change as CMS releases additional guidance.<\/p>\n<p style=\"color: #616161; font-size: 15px; line-height: 1.7; margin-bottom: 0;\"><strong>Last tested\/verified:<\/strong> June 30, 2026. <strong>Sources:<\/strong> CMS.gov, KFF.org, JAMA Network Open, Medicare Rights Center.<\/p>\n<\/div>\n<p><!-- COMMENT HOOK --><\/p>\n<div style=\"background: linear-gradient(135deg, #e8eaf6 0%, #c5cae9 100%); border-radius: 8px; padding: 24px; margin: 28px 0; text-align: center;\">\n<p style=\"color: #283593; font-size: 18px; font-weight: 600; margin-bottom: 8px;\">Have questions about the GLP-1 Medicare pilot program?<\/p>\n<p style=\"color: #3f51b5; font-size: 16px; margin-bottom: 0;\">Drop a comment below and we&#8217;ll help you figure out your eligibility. If you&#8217;ve already talked to your doctor about enrolling, share your experience. It helps other readers know what to expect.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Quick Answer Starting July 1, 2026, Medicare&#8217;s GLP-1 Bridge pilot program gives eligible Part D beneficiaries access to Wegovy, Zepbound, and Foundayo for a flat $50 per month. The program&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ai_generated_summary":"","footnotes":""},"categories":[5919],"tags":[6371,6373,6367,6369,6374,6372,6368,6370],"class_list":["post-105056","post","type-post","status-publish","format-standard","hentry","category-usa","tag-best-weight-loss-drugs-covered-by-medicare","tag-does-medicare-cover-zepbound-for-sleep-apnea","tag-glp-1-medicare-cost","tag-glp-1-medicare-eligibility","tag-is-wegovy-covered-by-medicare-part-b","tag-medicare-glp-1-bridge-details","tag-medicare-glp-1-coverage-2026","tag-when-will-medicare-cover-weight-loss-drugs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GLP-1 Medicare Pilot Program: $50 Access Starting July 2026 - Seminarsonly.com<\/title>\n<meta name=\"description\" content=\"The Medicare GLP-1 Bridge starts July 1, 2026. Get $50\/month access to Wegovy, Zepbound, and Foundayo. Learn eligibility, BMI tiers, and how to apply.Focus Keyword: GLP-1 Medicare pilot program\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026\" \/>\n<meta property=\"og:description\" content=\"The Medicare GLP-1 Bridge starts July 1, 2026. Get $50\/month access to Wegovy, Zepbound, and Foundayo. Learn eligibility, BMI tiers, and how to apply.Focus Keyword: GLP-1 Medicare pilot program\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Seminarsonly.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/seminarsonly\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T16:19:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T17:00:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg\" \/>\n<meta name=\"author\" content=\"Freddy John\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@seminarsonly\" \/>\n<meta name=\"twitter:site\" content=\"@seminarsonly\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Freddy John\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/\"},\"author\":{\"name\":\"Freddy John\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#\\\/schema\\\/person\\\/75cf706896b7210fb0a84651adc258bd\"},\"headline\":\"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026\",\"datePublished\":\"2026-06-29T16:19:56+00:00\",\"dateModified\":\"2026-06-29T17:00:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/\"},\"wordCount\":2080,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/glp1-medicare-pilot-program.jpg\",\"keywords\":[\"Best weight loss drugs covered by Medicare\",\"Does Medicare cover Zepbound for sleep apnea\",\"Glp 1 medicare cost\",\"Glp 1 medicare eligibility\",\"Is Wegovy covered by Medicare Part B\",\"Medicare GLP 1 Bridge details\",\"Medicare GLP-1 coverage 2026\",\"When will Medicare cover weight loss drugs\"],\"articleSection\":[\"USA\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/\",\"url\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/\",\"name\":\"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026 - Seminarsonly.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/glp1-medicare-pilot-program.jpg\",\"datePublished\":\"2026-06-29T16:19:56+00:00\",\"dateModified\":\"2026-06-29T17:00:37+00:00\",\"description\":\"The Medicare GLP-1 Bridge starts July 1, 2026. Get $50\\\/month access to Wegovy, Zepbound, and Foundayo. Learn eligibility, BMI tiers, and how to apply.Focus Keyword: GLP-1 Medicare pilot program\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/glp1-medicare-pilot-program.jpg\",\"contentUrl\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/glp1-medicare-pilot-program.jpg\",\"width\":1344,\"height\":768,\"caption\":\"glp-1 medicare pilot program\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/glp-1-medicare-pilot-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/\",\"name\":\"Seminarsonly.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#organization\",\"name\":\"Seminarsonly.com\",\"url\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Seminarsonly.com\"},\"image\":{\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/seminarsonly\",\"https:\\\/\\\/x.com\\\/seminarsonly\"],\"description\":\"Wings InfoTech\",\"legalName\":\"Wings InfoTech\",\"foundingDate\":\"2014-08-10\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"1\",\"maxValue\":\"10\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/#\\\/schema\\\/person\\\/75cf706896b7210fb0a84651adc258bd\",\"name\":\"Freddy John\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g\",\"caption\":\"Freddy John\"},\"sameAs\":[\"https:\\\/\\\/seminarsonly.com\\\/news\"],\"honorificPrefix\":\"Mr.\",\"gender\":\"male\",\"knowsAbout\":[\"PHP\",\"JavaScript\",\"Engineering\"],\"knowsLanguage\":[\"English\"],\"jobTitle\":\"Web Admin\",\"url\":\"https:\\\/\\\/seminarsonly.com\\\/news\\\/author\\\/anupvnaick_51wq8y4s\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026 - Seminarsonly.com","description":"The Medicare GLP-1 Bridge starts July 1, 2026. Get $50\/month access to Wegovy, Zepbound, and Foundayo. Learn eligibility, BMI tiers, and how to apply.Focus Keyword: GLP-1 Medicare pilot program","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/","og_locale":"en_US","og_type":"article","og_title":"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026","og_description":"The Medicare GLP-1 Bridge starts July 1, 2026. Get $50\/month access to Wegovy, Zepbound, and Foundayo. Learn eligibility, BMI tiers, and how to apply.Focus Keyword: GLP-1 Medicare pilot program","og_url":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/","og_site_name":"Seminarsonly.com","article_publisher":"https:\/\/facebook.com\/seminarsonly","article_published_time":"2026-06-29T16:19:56+00:00","article_modified_time":"2026-06-29T17:00:37+00:00","og_image":[{"url":"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg","type":"","width":"","height":""}],"author":"Freddy John","twitter_card":"summary_large_image","twitter_creator":"@seminarsonly","twitter_site":"@seminarsonly","twitter_misc":{"Written by":"Freddy John","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#article","isPartOf":{"@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/"},"author":{"name":"Freddy John","@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd"},"headline":"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026","datePublished":"2026-06-29T16:19:56+00:00","dateModified":"2026-06-29T17:00:37+00:00","mainEntityOfPage":{"@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/"},"wordCount":2080,"commentCount":2,"publisher":{"@id":"https:\/\/seminarsonly.com\/news\/#organization"},"image":{"@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#primaryimage"},"thumbnailUrl":"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg","keywords":["Best weight loss drugs covered by Medicare","Does Medicare cover Zepbound for sleep apnea","Glp 1 medicare cost","Glp 1 medicare eligibility","Is Wegovy covered by Medicare Part B","Medicare GLP 1 Bridge details","Medicare GLP-1 coverage 2026","When will Medicare cover weight loss drugs"],"articleSection":["USA"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/seminarsonly.com\/news\/#organization"}},{"@type":"WebPage","@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/","url":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/","name":"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026 - Seminarsonly.com","isPartOf":{"@id":"https:\/\/seminarsonly.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#primaryimage"},"image":{"@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#primaryimage"},"thumbnailUrl":"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg","datePublished":"2026-06-29T16:19:56+00:00","dateModified":"2026-06-29T17:00:37+00:00","description":"The Medicare GLP-1 Bridge starts July 1, 2026. Get $50\/month access to Wegovy, Zepbound, and Foundayo. Learn eligibility, BMI tiers, and how to apply.Focus Keyword: GLP-1 Medicare pilot program","breadcrumb":{"@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#primaryimage","url":"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg","contentUrl":"https:\/\/seminarsonly.com\/news\/wp-content\/uploads\/2026\/06\/glp1-medicare-pilot-program.jpg","width":1344,"height":768,"caption":"glp-1 medicare pilot program"},{"@type":"BreadcrumbList","@id":"https:\/\/seminarsonly.com\/news\/glp-1-medicare-pilot-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/seminarsonly.com\/news\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Medicare Pilot Program: $50 Access Starting July 2026"}]},{"@type":"WebSite","@id":"https:\/\/seminarsonly.com\/news\/#website","url":"https:\/\/seminarsonly.com\/news\/","name":"Seminarsonly.com","description":"","publisher":{"@id":"https:\/\/seminarsonly.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seminarsonly.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/seminarsonly.com\/news\/#organization","name":"Seminarsonly.com","url":"https:\/\/seminarsonly.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Seminarsonly.com"},"image":{"@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/seminarsonly","https:\/\/x.com\/seminarsonly"],"description":"Wings InfoTech","legalName":"Wings InfoTech","foundingDate":"2014-08-10","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"1","maxValue":"10"}},{"@type":"Person","@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd","name":"Freddy John","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g","caption":"Freddy John"},"sameAs":["https:\/\/seminarsonly.com\/news"],"honorificPrefix":"Mr.","gender":"male","knowsAbout":["PHP","JavaScript","Engineering"],"knowsLanguage":["English"],"jobTitle":"Web Admin","url":"https:\/\/seminarsonly.com\/news\/author\/anupvnaick_51wq8y4s\/"}]}},"_links":{"self":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts\/105056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/comments?post=105056"}],"version-history":[{"count":7,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts\/105056\/revisions"}],"predecessor-version":[{"id":105073,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts\/105056\/revisions\/105073"}],"wp:attachment":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/media?parent=105056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/categories?post=105056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/tags?post=105056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}